Fairfax, Va. (July 8, 2019) — Virginia Cancer Specialists (VCS) is pleased to welcome Elizabeth Feldman, MD, FACS, to the practice. A highly-skilled breast cancer surgeon, Dr. Feldman has years of rigorous education, training and experience in all recommended and nationally accepted surgical procedures for breast cancer, as well as expertise in the management of complex breast issues, enhancing VCS’ comprehensive breast care services. VCS, a practice in The US Oncology Network, is a premier cancer care and research center in Northern Virginia with more than 40 years of service to patients.
“Dr. Feldman is a great addition to our multidisciplinary breast team. She has many years of experience collaborating with other cancer specialists to develop personalized care plans with the goal of providing the best outcomes for patients,” said Linda Anderson, Executive Director, Virginia Cancer Specialists. “Her in-depth knowledge of nationally recognized surgical procedures for breast cancer and her experience working with the very latest clinical research protocols broadens our knowledge base and brings new energy and ideas to our breast care team. We are excited to provide our patients access to this compassionate and gifted breast surgery specialist.”
Dr. Feldman received her medical degree from the University of Maryland School of Medicine. She completed her internship at Penn State-Hershey Medical Center, as well as her first two years of residency. She then became a fellow at the National Cancer Institute, completing a three-year basic science and clinical research fellowship in Surgical Oncology. Dr. Feldman finished the remainder of her residency at Georgetown University Medical Center. After completing a Society of Surgical Oncology Breast Surgery Fellowship at Anne Arundel Medical Center in Annapolis, Md., she was an assistant professor in the Department of Surgery at Georgetown University Hospital.
“Dr. Feldman shares our vision of providing state-of-the-art multidisciplinary breast care, and we are delighted to have her join our growing practice,” noted VCS Medical Oncologist Amy Irwin, MD, a recognized expert in breast cancer and a member of The US Oncology Network Breast Cancer Research Committee. “Dr. Feldman is highly skilled in all of the traditional surgical procedures for breast cancer, as well as the new surgical advancements that are being made. She is a great addition to our breast team and will play an integral role as we collaborate to deliver the very best in personalized integrated care to our breast patients.”
In practice since 2008, Dr. Feldman is well-known and respected throughout the region and has been treating patients in Northern Virginia since 2013. She has been recognized as a “Top Doc” in both the Washingtonian and Northern Virginia Magazine for several years. Dr. Feldman is an active member of the American Society of Breast Surgeons as well as the American College of Surgeons where she serves on various committees. She has a special interest in nipple sparing mastectomy, oncoplastic breast conservation and patients who are at high risk for developing breast cancer.
“It was important for me to join a practice that is dedicated to providing patient-centered team care while also offering the very latest advanced treatments,” explained Dr. Feldman. “VCS has an excellent and well-deserved reputation as a world-class cancer center that believes in putting patients first. I look forward to collaborating with this group of compassionate, highly-skilled physicians as we help patients achieve the best possible outcomes.”
Virginia Cancer Specialists’ multidisciplinary breast care team includes surgeons dedicated exclusively to breast care, medical oncologists, radiation oncologists and other breast specialists who are experts in breast cancer and the care of complex breast issues. Virginia Cancer Specialists, which is the region’s leading research center, also offers numerous novel clinical trials for breast cancer, providing patients convenient access to leading-edge therapies close to home.
Dr. Feldman is now seeing patients at the Virginia Cancer Specialists Reston Treatment Center. Appointments may be made by calling 703.208.9395.
About Virginia Cancer Specialists
Virginia Cancer Specialists (VCS) has built a practice with a world-class treatment team fighting cancer and diseases of the blood, offering access to the most current treatment protocols, clinical trials, and comprehensive care all available in a community-based setting. With nine locations throughout Northern Virginia, staffed by more than 30 highly-skilled physicians, VCS delivers specialized, exceptional care. Virginia Cancer Specialists offers medical oncology, radiation oncology, musculoskeletal tumor surgery, breast surgery, thoracic surgery, genetic counseling, palliative care, oncology nurse navigators, oncology infusion nurses, oncology pharmacists, social workers and laboratory technicians. Our multidisciplinary team works together to design the optimal treatment program, efficiently sharing knowledge, and providing a patient-centered, consumer-friendly approach to cancer care. Patients receive a 360-degree full spectrum of high-quality care from a care team united in their effort to provide each patient with the personalized care they need to battle cancer.
Virginia Cancer Specialists has a well-established, fully staffed, comprehensive clinical research program with a dedicated research facility for Phase I clinical trials – the largest of its kind in the Northern Virginia area. Virginia Cancer Specialists is a practice in The US Oncology Network (The Network). This collaboration unites the practice with more than 1,200 independent physicians dedicated to delivering value-based, integrated care to patients — close to home. Through the Network, these independent doctors come together to form a community of shared expertise and resources dedicated to advancing local cancer care and to delivering better patient outcomes. The Network is supported by McKesson Corporation, whose coordinated resources and infrastructure allow doctors in The Network to focus on the health of their patients, while McKesson focuses on the health of their practices. VCS also participates in clinical trials through US Oncology Research, which has played a role in more than 85 FDA-approved cancer therapies, approximately one-third of all cancer therapies approved by the FDA to date.
Michelle Keene, Virginia Cancer Specialists